Dow Chemical and DuPont’s merger has crossed another hurdle on Thursday after receiving conditional EU approval for a divestment required by the US and EU competition regulators.
To secure approval for the mega-merger, DuPont agreed to sell a portion of its crop protection unit to FMC and in return acquire the vast majority of FMC’s health and nutrition business.
The asset swap’s EU approval is conditional on FMC selling off two of its herbicides, sulfonylurea and florasulam.
Full Content: Saint Louis Post-Dispatch
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Alaska Airlines’ Hawaiian Acquisition Faces Antitrust Scrutiny
Dec 6, 2023 by
CPI
Ulmer & Greensfelder Merge to Form UB Greensfelder
Dec 6, 2023 by
CPI
Apple’s iMessage May Be Exempt from New EU Regulations
Dec 6, 2023 by
CPI
UK Watchdog Warns Firms on AI Privacy Compliance
Dec 6, 2023 by
CPI
FTC Mounts Second Challenge to Microsoft’s Activision Buy Despite Closed Deal
Dec 6, 2023 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Horizontal Competition: Mergers, Innovation & New Guidelines
Nov 30, 2023 by
CPI
Innovation in Merger Control
Nov 30, 2023 by
CPI
Making Sense of EU Merger Control: The Need for Limiting Principles
Nov 30, 2023 by
CPI
Sustainability Agreements in the EU: New Paths to Competition Law Compliance
Nov 30, 2023 by
CPI
Merger Control and Sustainability: A New Dawn or Nothing New Under the Sun?
Nov 30, 2023 by
CPI